Comments on: IPF patients treated with OFEV® (nintedanib) versus placebo were twice as likely to have improved or stable lung function1

Comments on: IPF patients treated with OFEV® (nintedanib) versus placebo were twice as likely to have improved or stable lung function1 https://www.novumpr.nl/2017/05/24/ipf-patients-treated-with-ofev-nintedanib-versus-placebo-were-twice-as-likely-to-have-improved-or-stable-lung-function1/?utm_source=rss&utm_medium=rss&utm_campaign=ipf-patients-treated-with-ofev-nintedanib-versus-placebo-were-twice-as-likely-to-have-improved-or-stable-lung-function1 NovumPR press releases Wed, 24 May 2017 13:22:30 +0000 hourly 1 https://wordpress.org/?v=6.8.2